| Literature DB >> 24667838 |
Yan-Ping Huang1, Bin Chen1, Ping Ping1, Hong-Xiang Wang1, Kai Hu1, Hao Yang1, Tao Zhang1, Tan Feng1, Yan Jin1, Yin-Fa Han1, Yi-Xin Wang1, Yi-Ran Huang1.
Abstract
OBJECTIVES: To assess erectile function in middle-aged and older men with asexuality status and further analyze their specific reasons for this condition. SUBJECTS AND METHODS: Men who had regular sexual intercourse attempts (sex frequency ≥ 1 time per month) were classified into mild erectile dysfunction (ED), moderate to severe ED and non-ED according to International Index of Erectile Function-5, and men having no sexual intercourse attempts for at least 6 months were defined as having an asexuality status. The risk factors associated with ED were collected in a sample of 1,531 Chinese men aged 40 to 80 years, and the self-report reasons for asexuality were recorded in asexual cohort individually. Comparative analyses and multivariate regression models were conducted among these groups.Entities:
Mesh:
Year: 2014 PMID: 24667838 PMCID: PMC3965446 DOI: 10.1371/journal.pone.0092794
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The distribution of chronic disease and sexual status among age groups.
Figure 2The specific reasons for asexuality in the population without sexual intercourse.
Demographic and clinical characteristics of the participating men according to IIEF-5 score.
| Non-ED (N = 197) | Mild ED (N = 642) | Mo-Se ED(N = 123) | Asexuality(N = 569) |
| |
|
|
| ||||
|
| 56.84±8.92 | 59.77±8.63*† | 63.06±8.54* | 65.70±8.20*† | <0.001 |
|
| 24.17±3.54 | 24.34±3.48 | 24.50±3.12 | 24.17±3.66 | 0.705 |
|
| 83.03±6.95 | 82.82±8.81 | 84.41±6.49 | 82.44±7.22† | 0.091 |
|
| 128.36±16.04 | 129.58±15.04 | 128.63±15.50 | 132.16±17.72* | 0.005 |
|
| 82.25±8.97 | 82.39±8.87 | 81.69±9.52 | 81.76±9.47 | 0.625 |
|
| 74.14±4.58 | 73.76±5.65 | 74.09±5.50 | 74.08±5.59 | 0.703 |
|
| 23.22±0.96 | 17.07±2.62* | 8.13±2.22* | – | <0.001 |
|
| 5.51±1.71 | 5.53±1.58 | 5.59±1.52* | 5.95±2.34 | 0.070 |
|
| 74.73±10.49 | 75.32±13.02 | 75.19±10.35 | 76.97±17.01 | 0.114 |
|
| 4.52±2.97 | 4.49±2.37 | 4.45±2.15 | 4.19±2.19 | 0.629 |
|
|
| ||||
|
| 0.67 (0.09–13.20) | 0.74 (0.09–15.60) | 0.82 (0.09–24.00)* | 1.04 (0.09–48.00)*† | <0.001 |
|
| 5.43 (1.04–60.70) | 6.52 (0.43–69.01) | 4.65 (0.52–44.70)* | 6.80 (0.46–60.70)† | <0.001 |
|
| 4.19 (0.30–40.70) | 3.79 (0.20–30.20) | 3.63 (0.79–20.90) | 3.13 (0.36–21.90)† | 0.022 |
|
| 6.88 (0.48–51.27) | 7.62 (0.48–252.30) | 7.35 (0.83–34.84) | 7.78 (0.54–120.20) | 0.555 |
|
| 12.00 (12.00–139.00) | 12.00 (0.69–122.00) | 12.00 (12.00–104.00) | 12.00 (12.00–215.00) | 0.813 |
|
| 0.25 (0.03–1.17) | 0.26 (0.01–4.74) | 0.26 (0.02–0.77) | 0.22 (0.01–2.68) | 0.359 |
|
| 18.00 (5.00–178.00) | 18.00 (3.00–132.00) | 18.00 (4.00–86.00) | 19.00 (4.00–196.00) | 0.913 |
|
| 1.50 (0.48–19.23) | 1.45 (0.45–15.00) | 1.52 (0.43–6.48) | 1.52 (0.41–12.54) | 0.400 |
|
|
| ||||
|
| 75 (38.1) | 275 (42.8) | 58 (47.2) | 241 (42.4) | 0.440 |
|
| 72 (36.5) | 233 (36.3) | 50 (40.7) | 191 (33.6) | 0.457 |
|
| 116 (58.9) | 403 (62.8) | 80 (65.0) | 308 (54.1) | 0.011 |
|
| 108 (54.8) | 326 (50.8) | 55 (44.7) | 273 (48.0) | 0.235 |
|
| |||||
|
| 15 (7.6) | 70 (10.9) | 20 (16.3) | 94 (16.5)* | 0.002 |
|
| 52 (26.4) | 212 (33.0) | 47 (38.2) | 222 (39.0)* | 0.007 |
|
| 16 (8.1) | 54 (8.4) | 15 (12.2) | 46 (8.1) | 0.511 |
|
| 9 (4.6) | 42 (6.5) | 18 (14.6)* | 44 (7.7) | 0.006 |
|
| 2 (1.0) | 24 (3.7) | 7 (5.7) | 23 (4.0) | 0.133 |
Abbreviations: ED, erectile dysfunction; Mo-Se: moderate to severe; BMI, body mass index; WC, waist circumference; BP, blood pressure; HR, heart rate; IIEF-5, 5-item form of International Index of Erectile Function; FBG, fast blood glucose; TT, total testosterone;TPSA, total prostate specific antigen; FSH, follicle-stimulating hormone; LH, luteotropic hormone; PRL, prolactin; E, Estradiol; ALT, alanine transferase; TG, triglyceride; BPH, benign prostatic hyperplasia; PLS, prostatatis-like symptom; SD, standard deviation, Min, minimal; Max, maximum.
Data met normal distribution, using One-Way ANOVA analysis;
Data met non-normal distribution, using K-independent samples analysis;
Ranked data, using Chi-square tests analysis.
Bonferroni correction p: original p×4; *vs. Non-ED, p<0.05; †vs. Mo-Se ED, p<0.05.
Bivariate and multivariate association of impact factors with sexual function.
| Predictor | Mo-Se ED Vs. Non-ED | Asexuality status Vs. Non-ED | ||||||
| Odds Ratio (95% CI) | ||||||||
| Unadjusted |
| Adjusted |
| Unadjusted |
| Adjusted |
| |
|
| ||||||||
| 40–51 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 52–59 | 2.61(1.16–5.87) | 0.02 | 2.94 (1.26–6.83) | 0.01 | 3.05 (1.71–5.45) | <0.001 | 2.99 (1.66–5.40) | <0.001 |
| 60–64 | 4.41 (1.97–9.88) | <0.001 | 3.71 (1.57–8.77) | 0.003 | 8.56 (4.81–15.21) | <0.001 | 8.26(4.54–15.05) | <0.001 |
| 65–80 | 8.01 (3.62–17.71) | <0.001 | 7.19(3.03–17.10) | <0.001 | 18.49(10.34–33.05) | <0.001 | 17.69(9.59–32.61) | <0.001 |
|
| 1.57 (0.99–2.51) | 0.06 | 1.55(0.89–2.67) | 0.12 | 1.06 (075–1.49) | 0.75 | 1.04 (0.69–1.57) | 0.86 |
|
| 1.34 (0.81–2.21) | 0.26 | 1.49 (0.82–2.73) | 0.19 | 0.75 (0.51–1.11) | 0.15 | 0.81 (0.51–1.29) | 0.38 |
|
| ||||||||
|
| 0.69(0.44–1.09) | 0.11 | 0.92 (0.55–1.55) | 0.76 | 0.84 (0.60–1.17) | 0.29 | 0.93 (0.63–1.36) | 0.71 |
|
| 0.84(0.53–1.34) | 0.46 | 0.93 (0.55–1.58) | 0.79 | 1.14 (0.81–1.59) | 0.45 | 1.22 (0.83–1.80) | 0.32 |
|
| 0.77 (0.48–1.23) | 0.27 | 0.69 (0.41–1.16) | 0.16 | 1.21 (0.87–1.69) | 0.25 | 0.89 (0.61–1.31) | 0.57 |
|
| 1.50 (0.95–2.36) | 0.08 | 1.29 (0.76–2.18) | 0.35 | 1.32 (0.95–1.82) | 0.09 | 0.95 (0.65–1.39) | 0.79 |
|
| ||||||||
|
| 2.36 (1.16–4.80) | 0.02 | 1.76 (0.79–3.93) | 0.17 | 2.40 (1.36–4.25) | 0.003 | 1.79 (0.95–3.36) | 0.07 |
|
| 1.72 (1.07–2.79) | 0.03 | 1.11 (0.64–1.92) | 0.71 | 1.78(1.25–2.55) | 0.002 | 1.09 (0.73–1.66) | 0.65 |
|
| 1.57 (0.75–3.31) | 0.23 | 0.79 (0.34–1.85) | 0.59 | 0.99 (0.55–1.80) | 0.99 | 0.65 (0.33–1.28) | 0.22 |
|
| 3.58 (1.55–8.25) | 0.03 | 2.08 (0.81–5.29) | 0.13 | 1.75 (0.84–3.66) | 0.14 | 1.15 (0.51–2.61) | 0.73 |
|
| 5.88(1.20–28.79) | 0.03 | 4.32 (0.75–25.04) | 0.10 | 4.11 (0.96–17.58) | 0.06 | 3.53 (0.71–17.43) | 0.12 |
Abbreviations: ED, erectile dysfunction; CI, confidence interval; BMI, body mass index; WC, waist circumference; BPH, benign prostatic hyperplasia; PLS, prostatatis–like symptom, Vs., versus.
Multivariate regression: All variables listed in the table have been included in the multivariate logistic regression model simultaneously.